Versant Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.93K | Buy |
251
+96
| +62% | +$3.03K | ﹤0.01% | 1989 |
|
|
2025
Q1 | $5.14K | Hold |
155
| – | – | ﹤0.01% | 2018 |
|
|
2024
Q4 | $5.33K | Buy |
155
+140
| +933% | +$4.82K | ﹤0.01% | 1724 |
|
|
2024
Q3 | $600 | Hold |
15
| – | – | ﹤0.01% | 1840 |
|
|
2024
Q2 | $453 | Hold |
15
| – | – | ﹤0.01% | 1806 |
|
|
2024
Q1 | $504 | Hold |
15
| – | – | ﹤0.01% | 1689 |
|
|
2023
Q4 | $485 | Sell |
15
-7
| -32% | -$226 | ﹤0.01% | 1688 |
|
|
2023
Q3 | $721 | Hold |
22
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q2 | $774 | Hold |
22
| – | – | ﹤0.01% | 1690 |
|
|
2023
Q1 | $719 | Sell |
22
-44
| -67% | -$1.44K | ﹤0.01% | 1525 |
|
|
2022
Q4 | $3.64K | Hold |
66
| – | – | ﹤0.01% | 986 |
|
|
2022
Q3 | $3K | Buy |
66
+44
| +200% | +$2K | ﹤0.01% | 983 |
|
|
2022
Q2 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 1267 |
|